The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.
- Investigator
- Hans K Ghayee
- Status
- Accepting Candidates
- Ages
- 18 Years - 74 Years
- Sexes
- All
About me
Dr. Hans Ghayee received his osteopathic medical degree from the University of North Texas Health Science Center at Fort Worth. He did his Internal Medicine Residency at Johns Hopkins University/Sinai Hospital, followed by a fellowship in endocrinology at University of Texas Southwestern Medical Center.
Accepted insurances
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMy locations
Active clinical trials
My research
Top areas of exploration
- Pheochromocytoma , 24 publications
- Adrenal Gland Neoplasms , 23 publications
- Paraganglioma , 21 publications
- Succinate Dehydrogenase , 12 publications